Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), today announces positive topline results from the clinical study OX640-002. The study evaluated the performance in subjects with and without allergic ...
If you’ve heard the telltale cough and seen an infant gasp for breath, it’s easy to understand why a pertussis outbreak strikes fear in a parent’s heart.
But we'll be back tomorrow with more updates on the war in Ukraine. Here are the key lines from today: Outgoing US defence secretary Lloyd Austin announced a $500m (£407m) aid package for Ukraine ...
Micron Technology stock is the top performer in the this year, and while analysts are generally optimistic about its performance, some have lingering doubts. The stock rose 2.7% to $101.91 on Monday ...
Additional clinical results from Phase 1/2 study of MRT-2359 in MYC-driven solid tumors, including biomarker and activity data, anticipated in Q1 2025 MRT-8102, a NEK7-directed MGD targeting diseases ...